Day: December 29, 2021

Offer, buyback, cut-off price, pro rata and yield are presented in the table below:ISIN Offer mill. DKK (nominal) Buy-back mill. DKK (nominal) Cut-off price Pro rata Yield99 23997 DGB 0.25% 15/11/2022 220 0 – – –Total 220 0      

Bids, sales, stop-rates and prices are presented in the table below:      ISIN Bid Mill. kr. (nominal) Sale Stop-rate (per cent) Pro-rata Price98 18429 DKT 01/03/22 I 300 100 -0.675 100 % 100.107098 18502 DKT 01/06/22 II 0 0 – – –98 18692 DKT 01/09/22 III 0 0 – – –98 18775 DKT 01/12/22 IV 0 0 – – –Total 300 100      The sale will settle 3 January 2022.

UPPSALA, SWEDEN – LIDDS AB (publ) announced today that the systemic exposure of docetaxel after treating solid tumors with NanoZolid®-docetaxel is low and that the study demonstrated activity in both injected lesions and in systemic inflammatory markers. The results support further development of NanoZolid®-docetaxel. In October 2021, LIDDS announced the closing of the NZ-DTX-001 Phase I study. It was demonstrated that NanoZolid® in combination with docetaxel was safe and well tolerated, reaching the primary endpoint of the trial. After further analysis it is also concluded that the systemic NanoZolid®-docetaxel exposure is low and that activity in injected lesions is observed. Patients receiving docetaxel showed activation of systemic inflammatory biomarkers including IFN-gamma, CXCL9 and CXCL10. These molecules are considered important...

Press release, Helsinki, 29 December 2021 at 9:30 AM (EET) Nexstim Receives an NBS System Upgrade Order from a Finnish Hospital Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company”) has received an NBS 5 system order from a customer in Finland. Nexstim’s NBS (Navigated Brain Stimulation) system can be used, for example, in planning neurosurgery or radiation therapy after a patient has had a diagnosis of a brain tumor or other disorder. The NBS system is CE marked for pre-surgical mapping of the speech and motor cortices of the brain. Mikko Karvinen, CEO of Nexstim, comments: “We have been happy to see strong interest in system upgrades among our existing customers this year. In addition to acquiring new customers, maintaining long-term customer relationships is important to us. At Nexstim, we constantly work...

SAMPO PLC                 STOCK EXCHANGE RELEASE         29/12/2021 at 08:30 am Sampo plc’s share buybacks 28/12/2021 On 28/12/2021 Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI0009003305) as follows:                Sampo plc’s share buybacks Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares* Market (MIC Code)  21,978 44.39 AQEU  15,991 44.41 CEUX  4,407 44.38 TQEX  43,249 44.42 XHELTOTAL 85,625 44.41  *rounded to two decimals                 On 1 October 2021, Sampo announced a share buyback programme of up to a maximum of EUR 750 million in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The programme, which started on 4 October 2021,...

New York, New York, Dec. 28, 2021 (GLOBE NEWSWIRE) — Digital Health Acquisition Corp. (the “Company”) announced today that, commencing on or about December 30, 2021 holders of the units sold in the Company’s initial public offering completed on November 8, 2021, may elect to separately trade the shares of common stock and warrants in the units on The Nasdaq Global Market (“Nasdaq”).The shares of common stock and warrants that are separated will trade on Nasdaq under the symbols “DHAC” and “DHACW,” respectively. Those units not separated will continue to trade on Nasdaq under the symbol “DHACU.” Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, LLC, the Company’s transfer agent, in order to separate the units into shares of common stock and warrants.The units...

BEIJING, Dec. 29, 2021 (GLOBE NEWSWIRE) — JD.com, Inc. (the “Company” or “JD.com”) (Nasdaq: JD; HKEX: 9618), a leading supply chain-based technology and service provider, today announced that the Company’s Board of Directors has approved modifications to its existing share repurchase program adopted in March 2020, pursuant to which the repurchase authorization has increased from US$2.0 billion to US$3.0 billion and has been extended until March 17, 2024. About JD.comJD.com is a leading supply chain-based technology and service provider. The company’s cutting-edge retail infrastructure seeks to enable consumers to buy whatever they want, whenever and wherever they want it. The company has opened its technology and infrastructure to partners, brands and other sectors, as part of its Retail as a Service offering to help drive productivity...

BEIJING, Dec. 29, 2021 (GLOBE NEWSWIRE) — JD.com, Inc. (the “Company” or “JD.com”) (Nasdaq: JD; HKEX: 9618), a leading supply chain-based technology and service provider, today announced that it has entered into a five-year US$2.0 billion unsecured term and revolving loan facility with five lead arrangers. This loan facility is the Company’s first green loan facility. The term and revolving loans under this facility are priced at 85 basis points over LIBOR. The Company intends to use the proceeds from this loan facility to (i) finance or refinance in whole or in part, one or more of its new or existing eligible green projects and/or (ii) general corporate purposes. This loan facility remains subject to the final registration with the applicable regulatory authority in China. About JD.comJD.com is a leading supply chain-based technology...